rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Michael K. Handley

Chief Executive Officer

Company insider

Files Form 4 as: Chief Executive Officer, Valion Bio; President and CEO, Cytocom; VP Global Reg. Affairs & Comp, Spectranetics.

In numbers

Trades disclosed
13
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
3
Companies where not an officer
0
First trade
8 Dec 2008
Last trade
18 May 2026
Last filed
20 May 2026

Companies traded

Where they are an officer
VBIO Valion BioDirector, Officer · Biotechnology · last 18 May 20260 buys · 0 sells
CytocomDirector, Officer · last 27 Jul 20210 buys · 0 sells
SpectraneticsOfficer · last 8 Dec 20080 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
18 May 2026filed 20 May 2026VBIO Valion BioBiotechnologySEC FORM 4 Code M—2,206filing
18 May 2026filed 20 May 2026VBIO Valion Biooption or derivative · BiotechnologySEC FORM 4 Code M—2,206 at $0.00filing
18 May 2026filed 20 May 2026VBIO Valion Biooption or derivative · BiotechnologySEC FORM 4 Code M—2,206 at $0.00filing
18 May 2026filed 20 May 2026VBIO Valion BioBiotechnologySEC FORM 4 Code M—2,206filing
18 Feb 2026filed 20 Feb 2026Tivic Health SystemsBiotechnologySEC FORM 4 Code M—8,824filing
18 Feb 2026filed 20 Feb 2026Tivic Health Systemsoption or derivative · BiotechnologySEC FORM 4 Code M—8,824 at $0.00filing
18 Feb 2026filed 20 Feb 2026VBIO Valion Biooption or derivative · BiotechnologySEC FORM 4 Code M—8,824 at $0.00filing
18 Feb 2026filed 20 Feb 2026VBIO Valion BioBiotechnologySEC FORM 4 Code M—8,824filing
6 Aug 2025filed 22 Aug 2025VBIO Valion Biooption or derivative · BiotechnologySEC FORM 4 Code A—45,000 at $0.00filing
6 Aug 2025filed 8 Aug 2025VBIO Valion Biooption or derivative · BiotechnologySEC FORM 4 Code A—45,000 at $0.00filing
21 Feb 2025filed 24 Feb 2025VBIO Valion Biooption or derivative · BiotechnologySEC FORM 4 Code A—600,000 at $0.00filing
27 Jul 2021filed 4 Aug 2021CytocomSEC FORM 4 Code A—296,609 at $0.00filing
8 Dec 2008filed 10 Dec 2008Spectraneticsoption or derivativeSEC FORM 4 Code A—22,500filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Lisa G. WolfCOO & CFO · COO & CFO at Valion Bio, filing Form 4 there in the last year
Dean ZikriaInterim CEO · Interim CEO at Valion Bio, filing Form 4 there in the last year
Melinda LackeyGeneral Counsel & SVP of Legal · General Counsel & SVP of Legal at Valion Bio, filing Form 4 there in the last year
Sheryle BoltonDirector · Director at Tivic Health Systems, filing Form 4 there in the last year
Christina Rizopoulos ValauriDirector · Director at Tivic Health Systems, filing Form 4 there in the last year